Segment Information (Tables)

9 Months Ended

Mar. 31, 2025

Segment Reporting [Abstract]

Schedule of Revenue by Segment and Reconciling Items

The table below presents a reconciliation of net revenues and net operating profit by reportable segments (in thousands):

	Three Months Ended March 31,				Nine Months Ended March 31,
	2025		2024		2025		2024
Net revenue by segment
Sleep and Breathing Health	$	1,130,575	$	1,049,023	$	3,323,905	$	3,029,915
Residential Care Software	161,161		147,957		474,429		432,187
Total	$	1,291,736	$	1,196,980	$	3,798,334	$	3,462,102
Depreciation and amortization by segment
Sleep and Breathing Health	$	22,818	$	21,832	$	71,087	$	64,307
Residential Care Software	2,251		2,358		6,859		7,843
Amortization of acquired intangible assets and corporate assets	18,606		19,284		56,899		61,042
Total	$	43,675	$	43,474	$	134,845	$	133,192
Net operating profit by segment
Sleep and Breathing Health	$	494,796	$	456,182	$	1,444,492	$	1,240,061
Residential Care Software (1)	53,179		38,754		149,682		111,846
Total	$	547,975	$	494,936	$	1,594,174	$	1,351,907
Reconciling items
Corporate costs	$	103,368	$	101,336	$	307,258	$	274,505
Amortization of acquired intangible assets	18,339		19,016		56,093		60,235
Restructuring expenses	—		—		—		64,228
Masks with magnets field safety notification expenses (2)	—		—		—		6,351
Astral field safety notification expenses (3)	—		—		—		7,911
Interest expense (income), net	(793)		11,026		1,643		39,787
(Gain) Loss attributable to equity method investments	(335)		(440)		(2,375)		2,716
Loss on equity investments	5,647		(13,919)		7,765		(11,429)
Other, net	4,056		2,496		4,277		537
Income before income taxes	$	417,693	$	375,421	$	1,219,513	$	907,066

(1)    During the three and nine months ended March 31, 2024, we recorded $2.0 million of operating lease right-of-use asset impairments within our Residential Care Software segment. The impairments related to leases for office space and were recorded within net operating profit.

(2)    The masks with magnets field safety notification expenses relate to estimated costs to provide alternative masks to patients in response to updated contraindications for use of masks that incorporate magnets.

(3)    The Astral field safety notification expenses relate to estimated costs associated with the replacement of a certain component in some of our Astral ventilation devices that were manufactured between 2013 to 2019.